You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Ohm Labs Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for OHM LABS INC, and what generic and branded alternatives to OHM LABS INC drugs are available?

OHM LABS INC has three approved drugs.

There is one tentative approval on OHM LABS INC drugs.

Summary for Ohm Labs Inc
US Patents:0
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Ohm Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ohm Labs Inc VALSARTAN valsartan TABLET;ORAL 077492-001 Jun 26, 2014 AB RX No No ⤷  Subscribe ⤷  Subscribe
Ohm Labs Inc VALSARTAN valsartan TABLET;ORAL 077492-002 Jun 26, 2014 AB RX No No ⤷  Subscribe ⤷  Subscribe
Ohm Labs Inc GUAIFENESIN guaifenesin TABLET, EXTENDED RELEASE;ORAL 209254-002 Jul 16, 2018 OTC No No ⤷  Subscribe ⤷  Subscribe
Ohm Labs Inc VALSARTAN valsartan TABLET;ORAL 077492-004 Jun 26, 2014 AB RX No No ⤷  Subscribe ⤷  Subscribe
Ohm Labs Inc EZETIMIBE ezetimibe TABLET;ORAL 207311-001 Jun 12, 2017 AB RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.